Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma (Q38549102)

4 September 2017

Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma (English)

1 reference

4 September 2017

Williams JA

1

1 reference

4 September 2017

Yuan X

2

1 reference

4 September 2017

Dillehay LE

3

1 reference

4 September 2017

Shastri VR

4

1 reference

4 September 2017

Brem H

5

1 reference

4 September 2017

Williams JR

6

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

International Journal of Radiation Oncology Biology Physics

4 September 2017

1 reference

4 September 2017

42

1 reference

4 September 2017

3

1 reference

4 September 2017

631-639

1 reference

Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation.

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

MOLECULAR RADIOBIOLOGY OF HUMAN CELL LINES. V. COMPARATIVE RADIOSENSITIZING PROPERTIES OF 5-HALODEOXYCYTIDINES AND 5-HALODEOXYURIDINES.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

A phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Intraarterial iododeoxyuridine infusion combined with irradiation. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Long-term follow-up on National Cancer Institute Phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: a comparison of short versus long intravenous dose schedules (RTOG 86-12).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Intra-arterial 5-bromodeoxyuridine and x-ray therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Blood-brain barrier: a definition of normal and altered function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Polymers to treat brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Erosion kinetics of hydrolytically degradable polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Enhanced delivery of 5-iodo-2'-deoxyuridine to the brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

Brain parenchymal metabolism of 5-iodo-2'-deoxyuridine and 5'-ester prodrugs

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900258-2

7 January 2021

10.1016/S0360-3016(98)00258-2

Identifiers

DOI

1 reference

4 September 2017

1 reference